Home > Business > PTI > Report

Ranbaxy to buy RPG Aventis in France

December 13, 2003 14:50 IST

Ranbaxy Laboratories Ltd will acquire RPG Aventis SA along with its fully-owned subsidiary, OPIH SARL, in France for an undisclosed sum.

The companies have signed an agreement to this effect, but the sale was subject to the legal process of consultation with employee representatives, Ranbaxy informed the Bombay Stock Exchange on Saturday.

"France is strategic to our European expansion plans. The acquisition of RPG Aventis will be a very important move for Ranbaxy as it would place us among the top generic companies in the French market," Ranbaxy chief executive officer and managing director D S Brar said.

The transaction is expected to be completed in the first quarter of 2004, subject to the requisite approvals, the pharma major said.


Article Tools
Email this article
Print this article
Write us a letter



Related Stories


Ranbaxy plans Hyderabad units








© Copyright 2003 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.











Copyright © 2003 rediff.com India Limited. All Rights Reserved.